MARK CORRIGAN Insider Trading $NBRV Nabriva Therapeutics plc

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for MARK CORRIGAN.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of MARK CORRIGAN. MARK CORRIGAN is Executive VP, R&D in Sunovion Pharmaceuticals Inc. ($SEPR) and Executive, VP R&D in Sunovion Pharmaceuticals Inc. ($SEPR) and Director in NOVELION THERAPEUTICS INC. ($QLTI) and Director in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and Director in CoLucid Pharmaceuticals, Inc. ($CLCD) and Director in Wave Life Sciences Ltd. ($WVE) and Director in Nabriva Therapeutics plc ($NBRV) and Director in Nabriva Therapeutics Plc ($NBRV).

MARK CORRIGAN in Nabriva Therapeutics plc

Trading Symbol: NBRV
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARK CORRIGAN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Aug 01 2019
$NBRV Market Capitalization: $180.88M
$NBRV Previous Close: $8.09

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of MARK CORRIGAN in Nabriva Therapeutics plc

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, CLCD, CRXX, NBRV, NBRV, NVLN, SEPR, WVE

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Shares	Total Shares
Aug 01 2019	NBRV	Nabriva Therapeuti ...	CORRIGAN MARK	Director	Option Exercise	A	35,000	35,000
May 04 2018	NBRV	Nabriva Therapeuti ...	CORRIGAN MARK	Director	Option Exercise	A	29,000	29,000
Sep 19 2017	NBRV	Nabriva Therapeuti ...	CORRIGAN MARK	Director	Option Exercise	A	10,100	10,100

Page: 1